Skip to main content
. 2023 Sep 13;23:660. doi: 10.1186/s12884-023-05970-2

Table 4.

Primary outcomes of allylestrenol versus dydrogesterone stratified by the number of embryo transferred

Embryo(s) Transferred Variables Dydrogesterone (N = 989) Allylestrenol (N = 989) P-value
1 Number of participants 257 372
ART outcome (%)
Clinical pregnancy 124 (48.2) 205 (55.1) 0.107
Non-pregnancy 106 (41.2) 148 (39.8) 0.776
Biochemical pregnancy 27 (10.5) 19 (5.1) 0.016*
Clinical pregnancy outcomes (%)
Live birth 99 (38.52) 171 (45.97) 0.076
Abortion 8 (3.11) 10 (2.69) 0.810
Embryonic demise 15 (5.84) 21 (5.65) 1.000
Labor induction 2 (0.78) 3 (0.81) 1.000
Multiple gestations (%) 2 (1.6) 1 (0.5) 0.658
Number of implantations 0.059
0 131 (51.0) 166 (44.6)
1 124 (48.2) 206 (55.4)
2 2 (0.8) 0 (0.0)
3 0(0.0) 0(0.0)
2 Number of participants 680 602
ART outcome (%)
Clinical pregnancy 381 (56.0) 320 (53.2) 0.329
Non-pregnancy 216 (31.8) 241 (40.0) 0.002*
Biochemical pregnancy 83 (12.2) 41 (6.8) 0.002*
Clinical pregnancy outcomes (%)
Live birth 308 (45.29) 242 (40.20) 0.075
Abortion 22 (3.24) 26 (4.32) 0.382
Embryonic demise 39 (5.74) 37 (6.15) 0.847
Labor induction 12 (1.76) 15 (2.49) 0.479
Multiple gestations (%) 104 (27.3) 67 (20.9) 0.062
Number of implantations 0.170
0 296 (43.5) 275 (45.7)
1 246 (36.2) 227 (37.7)
2 135 (19.9) 100 (16.6)
3 3 (0.4) 0 (0.0)
3 Number of participants 52 11
ART Outcome (%)
Clinical pregnancy 21 (40.4) 3 (27.3) 0.637
Non-pregnancy 24 (46.2) 5 (45.5) 1.000
Biochemical pregnancy 7 (13.5) 3 (27.3) 0.494
Clinical Pregnancy Outcomes (%)
Live birth 15 (28.85) 2 (18.18) 0.712
Abortion 4 (7.69) 0 (0.0) 1.000
Embryonic demise 1 (1.92) 1 (9.09) 0.321
Labor induction 1 (1.92) 0 (0.0) 1.000
Multiple gestations (%) 5 (23.8) 1 (33.3) 1.000
Number of implantations 0.698
0 31 (59.6) 8 (72.7)
1 12 (23.1) 2 (18.2)
2 4 (7.7) 1 (9.1)
3 5 (9.6) 0 (0.0)

ART assisted reproductive techniques

*P < 0.05